• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫重建小鼠注射肿瘤疫苗后的抗肿瘤免疫反应。

Anti-tumor immune responses in immune-reconstituted mice injected with a tumor vaccine.

机构信息

Department of Hematology, Second Affiliated Hospital, Medical School of Xi'an Jiaotong University, Xi'an, 710004 Shaanxi Province, China.

出版信息

Med Oncol. 2012 Sep;29(3):2261-9. doi: 10.1007/s12032-011-0024-8. Epub 2011 Jul 15.

DOI:10.1007/s12032-011-0024-8
PMID:21761245
Abstract

Homeostasis-driven proliferation of T cells is an important means of reconstituting T-cell-dependent immunity after lymphodepletion regimens, such as chemotherapy or radiotherapy. Immune-reconstituted mice that receive a tumor vaccine mount more efficient anti-tumor immune responses compared with control mice. In the present study, we evaluated the anti-tumor immune responses in immune-reconstituted mice vaccinated with inactivated leukemia cells and explored the mechanisms underlying these immune responses. Test C57BL/6 mice were lymphodepleted by irradiation and immune-reconstituted with naïve mouse spleen lymphocytes. Mice were then injected with an inactivated FBL-3 tumor cell vaccine and challenged with FBL-3 tumor cells. Anti-tumor responses were evaluated by determining the rate of tumor formation, latency, tumor size, interferon gamma levels, and macrophage and CTL cytotoxicities. When challenged with tumor cells, immune-reconstituted, vaccinated mice exhibited a significantly lower mortality, smaller average tumor volume, and a significantly longer mean survival time. They had more robust cellular immunity, reflected by higher levels of INF-γ production and higher macrophage- and CTL-mediated cytotoxicities. Our results suggest that immune reconstitution enhanced the anti-tumor immune responses in mice injected with a tumor vaccine via generation of CTLs. These results have important implications for immunotherapy used for leukemia.

摘要

在化疗或放疗等淋巴耗竭方案后,通过细胞的稳态增殖来重建 T 细胞依赖的免疫是一种重要的手段。与对照组小鼠相比,接受肿瘤疫苗免疫重建的小鼠会产生更有效的抗肿瘤免疫反应。在本研究中,我们评估了用灭活白血病细胞免疫重建的小鼠的抗肿瘤免疫反应,并探索了这些免疫反应的机制。实验选用 C57BL/6 小鼠,通过照射进行淋巴耗竭,并用幼稚的小鼠脾淋巴细胞进行免疫重建。然后,将小鼠用灭活的 FBL-3 肿瘤细胞疫苗进行免疫接种,并接受 FBL-3 肿瘤细胞的攻击。通过测定肿瘤形成率、潜伏期、肿瘤大小、干扰素 γ 水平以及巨噬细胞和 CTL 细胞毒性来评估抗肿瘤反应。当受到肿瘤细胞攻击时,接受疫苗免疫重建的小鼠的死亡率显著降低,平均肿瘤体积更小,平均存活时间显著延长。它们具有更强的细胞免疫,表现为更高水平的 INF-γ 产生和更高的巨噬细胞和 CTL 介导的细胞毒性。我们的结果表明,通过生成 CTL,免疫重建增强了接受肿瘤疫苗注射的小鼠的抗肿瘤免疫反应。这些结果对于白血病的免疫治疗具有重要意义。

相似文献

1
Anti-tumor immune responses in immune-reconstituted mice injected with a tumor vaccine.免疫重建小鼠注射肿瘤疫苗后的抗肿瘤免疫反应。
Med Oncol. 2012 Sep;29(3):2261-9. doi: 10.1007/s12032-011-0024-8. Epub 2011 Jul 15.
2
[The anti-leukemia effects of IL-2 and IL-3 genes co-transfected leukemia vaccine].白细胞介素-2与白细胞介素-3基因共转染白血病疫苗的抗白血病作用
Zhonghua Xue Ye Xue Za Zhi. 1997 Dec;18(12):630-3.
3
Her-2 DNA versus cell vaccine: immunogenicity and anti-tumor activity.人表皮生长因子受体2(Her-2)DNA疫苗与细胞疫苗:免疫原性和抗肿瘤活性
Cancer Immunol Immunother. 2009 May;58(5):759-67. doi: 10.1007/s00262-008-0599-x. Epub 2008 Oct 3.
4
Virus-Like Particles Presenting the FGF-2 Protein or Identified Antigenic Peptides Promoted Antitumor Immune Responses in Mice.携带 FGF-2 蛋白或鉴定的抗原肽的病毒样颗粒在小鼠中促进抗肿瘤免疫反应。
Int J Nanomedicine. 2020 Mar 24;15:1983-1996. doi: 10.2147/IJN.S237182. eCollection 2020.
5
Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells.基于痘病毒的主动免疫疗法与CTLA-4阻断协同作用,通过提高细胞毒性T细胞的数量和质量来提高小鼠肿瘤模型的生存率。
Cancer Immunol Immunother. 2016 May;65(5):537-49. doi: 10.1007/s00262-016-1816-7. Epub 2016 Mar 10.
6
[New strategy of cancer immunotherapy: irradiation or chemotherapeutics-induced lymphopenia combined with immune reconstitution and tumor vaccine].[癌症免疫治疗的新策略:放疗或化疗诱导的淋巴细胞减少联合免疫重建与肿瘤疫苗]
Zhonghua Zhong Liu Za Zhi. 2005 Aug;27(8):452-6.
7
Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine.使用分泌粒细胞-巨噬细胞集落刺激因子(GM-CSF)的同种异体肿瘤细胞疫苗进行抗原特异性癌症免疫治疗。
Int J Cancer. 2000 Jun 1;86(5):725-30. doi: 10.1002/(sici)1097-0215(20000601)86:5<725::aid-ijc19>3.0.co;2-k.
8
An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen.1型干扰素在通过与模型肿瘤抗原共包封的CpG脂质体诱导CTL介导的已建立肿瘤组织完全根除中起不可或缺的作用。
Int Immunol. 2006 Mar;18(3):425-34. doi: 10.1093/intimm/dxh381. Epub 2006 Jan 13.
9
The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.细胞因子基因共转导对使用表达肿瘤相关抗原的基因修饰树突状细胞进行癌症疫苗治疗的增强作用。
Int J Oncol. 2006 Apr;28(4):947-53.
10
Vaccination with liposome-coupled glypican-3-derived epitope peptide stimulates cytotoxic T lymphocytes and inhibits GPC3-expressing tumor growth in mice.用脂质体偶联的磷脂酰肌醇蛋白聚糖-3衍生表位肽进行疫苗接种可刺激细胞毒性T淋巴细胞,并抑制小鼠中表达GPC3的肿瘤生长。
Biochem Biophys Res Commun. 2016 Jan 1;469(1):138-143. doi: 10.1016/j.bbrc.2015.11.084. Epub 2015 Nov 23.

引用本文的文献

1
antitumor activity evaluation of cancer vaccines prepared by various antigen forms in a murine hepatocellular carcinoma model.在小鼠肝细胞癌模型中对由各种抗原形式制备的癌症疫苗的抗肿瘤活性评估。
Oncol Lett. 2017 Dec;14(6):7391-7397. doi: 10.3892/ol.2017.7169. Epub 2017 Oct 11.

本文引用的文献

1
Dendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccination.树突状细胞在淋巴耗竭后的恢复:一种用于抗癌过继性 T 细胞治疗和疫苗接种的潜在机制。
Cancer Immunol Immunother. 2010 Mar;59(3):341-53. doi: 10.1007/s00262-009-0792-6. Epub 2009 Nov 18.
2
Partial CD4 depletion reduces regulatory T cells induced by multiple vaccinations and restores therapeutic efficacy.部分 CD4 细胞耗竭可减少多次疫苗接种诱导的调节性 T 细胞,并恢复治疗效果。
Clin Cancer Res. 2009 Nov 15;15(22):6881-90. doi: 10.1158/1078-0432.CCR-09-1113. Epub 2009 Nov 10.
3
Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response.
通过去除CD25 T细胞,基于树突状细胞的抗急性髓系白血病疫苗的疗效显著提高,从而能够诱导持久的T细胞反应。
Cancer Immunol Immunother. 2009 Oct;58(10):1669-77. doi: 10.1007/s00262-009-0678-7. Epub 2009 Feb 19.
4
Monocyte-derived dendritic cells from HLA-matched allogeneic donors showed a greater ability to induce leukemic cell-specific T cells in comparison to leukemic cell-derived dendritic cells or monocyte-derived dendritic cells from AML patients.与白血病细胞来源的树突状细胞或急性髓系白血病患者的单核细胞来源的树突状细胞相比,来自HLA匹配的同种异体供体的单核细胞来源的树突状细胞诱导白血病细胞特异性T细胞的能力更强。
Leuk Res. 2008 Nov;32(11):1653-60. doi: 10.1016/j.leukres.2008.03.038. Epub 2008 May 22.
5
Enhanced T-cell immunity induced by dendritic cells with phagocytosis of heat shock protein 70 gene-transfected tumor cells in early phase of apoptosis.在凋亡早期,树突状细胞吞噬热休克蛋白70基因转染的肿瘤细胞所诱导的增强型T细胞免疫。
Cancer Gene Ther. 2007 Apr;14(4):409-20. doi: 10.1038/sj.cgt.7701025. Epub 2007 Jan 19.
6
Dendritic cells pulsed or fused with AML cellular antigen provide comparable in vivo antitumor protective responses.用急性髓系白血病细胞抗原脉冲或融合的树突状细胞可提供相当的体内抗肿瘤保护性反应。
Exp Hematol. 2006 Oct;34(10):1403-12. doi: 10.1016/j.exphem.2006.05.011.
7
DC-based vaccine loaded with acid-eluted peptides in acute myeloid leukemia: the importance of choosing the best elution method.基于树突状细胞的急性髓系白血病酸洗脱肽负载疫苗:选择最佳洗脱方法的重要性
Cancer Immunol Immunother. 2007 Jan;56(1):1-12. doi: 10.1007/s00262-006-0170-6. Epub 2006 May 5.
8
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells.通过淋巴细胞清除去除稳态细胞因子库可增强过继转移的肿瘤特异性CD8 + T细胞的疗效。
J Exp Med. 2005 Oct 3;202(7):907-12. doi: 10.1084/jem.20050732.
9
Assessment of selected co-stimulatory, adhesion and activatory molecules and cytokines of Th(1)/Th(2) balance in acute lymphoblastic leukemia in children.儿童急性淋巴细胞白血病中Th(1)/Th(2)平衡相关的特定共刺激、黏附及激活分子和细胞因子的评估
Arch Immunol Ther Exp (Warsz). 2005 Jul-Aug;53(4):357-63.
10
Manipulating the host response to autologous tumour vaccines.操控宿主对自体肿瘤疫苗的反应。
Dev Biol (Basel). 2004;116:93-107; discussion 133-43.